Skip to main content
Clinical Trials/CTRI/2022/10/046321
CTRI/2022/10/046321
Completed
Phase 4

A prospective, single arm, post market clinical follow-up of Infusion Set to explore its safety and performance in Adult & Paediatric subjects in Indian Population.

Romsons Group Private Limited0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Romsons Group Private Limited
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 29, 2023
Last Updated
2 years ago
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Males and Females (Adult \& Paediatric) who are expected to require Infusion Set.
  • 2\.Subject who can provide Informed Consent Form (Adult) in writing and medically in a position to undergo consent and screening process OR in case of Paediatrics, parent of child/LAR (Legally Acceptable Representative) can provide Informed Assent Form (Child).
  • 3\.The subject is willing and able to comply with the requirement of the follow\-up. OR in case of Paediatrics, parent of child/LAR (Legally Acceptable Representative) who is willing and able to comply with the requirement of the follow\-up.

Exclusion Criteria

  • 1\.Subject who present with medical emergency, where treatment is more priority than the informed consent/informed assent process.
  • 2\.Subject with bleeding disorder, extensive malignant skin involvement, multicoated effusions, located fluid accumulations, hepatic hydrithorax.
  • 3\.Subject, who cannot provide Informed Consent Form (Adult) such as unconscious, mentally challenged subject, OR in case of Paediatrics, parent of child/LAR (Legally Acceptable Representative) who cannot provide Informed Assent Form (Child) or give permission etc.
  • 4\.Any known allergy with any of the material of Infusion Set and its component(s).
  • 5\.Subject who is pregnant or breast feeding.
  • 6\.Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital.
  • 7\.Participation in another research study involving an active investigation within 30 days prior to consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials